Sino Biopharmaceutical Limited (1177.HK) HKSE

6.84

-0.04(-0.58%)

Updated at December 05 02:45PM

Currency In HKD

Valuation

Market Cap51.83B
Enterprise Value52.04B
P/E Ratio28.9
PEG Ratio0.77
Price/Sales Ratio3.63
Price/Book Ratio3.35
Enterprise/Revenue3.66
Enterprise/EBITDA18.3

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.2

Management Effectiveness

Return On Assets0.05
Return On Equity0.12

Income Statement

Revenue28.87B
Revenue/Share1.7
Gross Profit23.53B
EBITDA6.11B
Net Income3.5B
Diluted EPS0.19

Balance Sheet

Total Cash19.82B
Total Cash/Share0.62
Total Debt11.96B
Total Debt/Equity0.36
Current Ratio1.36
Book Value Per Share2.54

Price History

52-Week Change111.11
52-Week High9.12
52-Week Low2.67
Moving Average 50 Days7.34
Moving Average 200 Days5.86

Statistics

Average Volume100.08M
Shares Outstanding17.89B
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield1.32
Payout Ratio0
Last Split Factor3:2
Last Split DateJuly 20, 2020